B cell response to pneumococcal vaccines

B cell response to pneumococcal vaccines

<p><em>Streptococcus pneumoniae</em> is a significant cause of mortality and morbidity in both children and older adults, with infection resulting in invasive disease, pneumonia and otitis media. The inclusion of pneumococcal conjugate vaccines in routine infant immunisation progra...

Szczegółowa specyfikacja

Opis bibliograficzny
1. autor:	Trück, J
Kolejni autorzy:	Pollard, AJ
Format:	Praca dyplomowa
Język:	English
Wydane:	2014
Hasła przedmiotowe:	Medical sciences Vaccinology Infectious diseases Immunology Genetics (medical sciences) Paediatrics

Podobne zapisy

Genetics determinants of vaccine responses
od: O'Connor, D
Wydane: (2014)

Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins
od: Lee, Y, i wsp.
Wydane: (2006)

Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response.
od: Matsumiya, M, i wsp.
Wydane: (2014)

What are the implications for childhood pneumonia of successfully introducing hib and pneumococcal vaccines in developing countries?
od: Scott, J, i wsp.
Wydane: (2008)

Host genetic factors and vaccine-induced immunity to hepatitis B virus infection
od: Hennig, B, i wsp.
Wydane: (2008)

Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
od: Antrobus, R
Wydane: (2014)

Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
od: Elias, SC
Wydane: (2014)

The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM197 conjugate vaccine
od: Clutterbuck, E, i wsp.
Wydane: (2006)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
od: Harris, S, i wsp.
Wydane: (2013)

Innate immune responses to tuberculosis vaccines
od: Matsumiya, M
Wydane: (2014)

Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants
od: Ruggeberg, J, i wsp.
Wydane: (2007)

Understanding vaccine induced protective immunity to Mycobacterium tuberculosis
od: Ronan, E
Wydane: (2011)

Understanding the link between interleukin 17 and vaccine-induced protection in tuberculosis
od: Griffiths, K
Wydane: (2012)

T cell responses in Kenyan infants: impact on HIV-1 evolution during infection and an assessment of vaccine-induced memory responses in HIV-exposed uninfected infants
od: Garcia Knight, M
Wydane: (2014)

A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial
od: Pace, D, i wsp.
Wydane: (2008)

Characterisation of T cells induced by candidate conserved region HIV-1 vaccines in healthy HIV-1/2 negative volunteers
od: Ahmed, T, i wsp.
Wydane: (2014)

Evaluation of a potential vaccine against hyperinvasive serogroup B Neisseria meningitidis by assessment of the effects of surface-expressed Opacity-associated proteins on the immune system
od: Sadarangani, M
Wydane: (2011)

The design and development of an HIV-1 vaccine to elicit a broadly neutralising antibody response
od: Wan, L, i wsp.
Wydane: (2012)

Evaluation of immune correlates to TB vaccines
od: Marsay, L
Wydane: (2011)

Long term efficacy of a pre-erythrocytic malaria vaccine and correlates of protection in children residing in a malaria endemic country
od: Olotu, A
Wydane: (2013)

HIV-specific interleukin-10 responses and immune modulation
od: Clutton, G
Wydane: (2012)

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations
od: Hanekom, W, i wsp.
Wydane: (2008)

Comparison of a limiting dilution assay and ELISpot for detection of memory B-cells before and after immunisation with a protein-polysaccharide conjugate vaccine in children
od: Blanchard-Rohner, G, i wsp.
Wydane: (2010)

B cell responses to conjugate and polysaccharide meningococcal vaccines
od: Ramasamy, M
Wydane: (2012)

Developing novel blood-stage malaria vaccines
od: Douglas, AD
Wydane: (2015)

Innate immune pathways controlling IL-1beta production and adjuvant-induced T helper 17 cell differentiation
od: Shenderov, K
Wydane: (2011)

Towards improved blood-stage malaria vaccines: characterising the underlying immunogenicity of vaccine adjuvants and vectors
od: de Cassan, S
Wydane: (2011)

Pre-clinical development of viral vectored transmission-blocking malaria vaccines
od: Kapulu, MC
Wydane: (2014)

T-cell receptor (TCR) usage in HIV-2 infection
od: Moysi, E
Wydane: (2012)

Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial
od: Diggle, L, i wsp.
Wydane: (2006)

Antibody-based HIV-1 vaccines: recent developments and future directions
od: Montefiori, D, i wsp.
Wydane: (2007)

A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods
od: Warrell, M, i wsp.
Wydane: (2008)

Haemophilus influenzae Type b vaccine failure in children is associated with inadequate production of high-quality antibody
od: Lee, Y, i wsp.
Wydane: (2008)

Refocusing antibody responses by chemical modification of vaccine antigens
od: Schiffner, T
Wydane: (2014)

B cell and antibody responses to influenza a virus in human
od: Huang, K
Wydane: (2011)

A randomised study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide - CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge phase
od: Riddell, A, i wsp.
Wydane: (2007)

Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
od: Bauza, K
Wydane: (2012)

Memory T cell responses in influenza A infection and vaccination in humans
od: Chui, C
Wydane: (2012)

New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
od: Alharbi, N
Wydane: (2014)

Development of antimalarial human monoclonal antibodies against Plasmodium falciparum
od: Wang, LT
Wydane: (2022)